Screening compound: KNZDVGRWWNDHLR-GOSISDBHSA-N

Screening compound: KNZDVGRWWNDHLR-GOSISDBHSA-N
Screening compound: KNZDVGRWWNDHLR-GOSISDBHSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
KNZDVGRWWNDHLR-GOSISDBHSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S635-2602

Molecular Formula

C22H27N5O (C22 H27 N5 O)

Compound Name

{8-[(1H-indol-3-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol

IUPAC name

{8-[(1H-indol-3-yl)methyl]-2-(pyrimidin-4-yl)-28-diazaspiro[4.5]decan-4-yl}methanol

SMILES

OCC(CN(C1)c2ncncc2)C11CCN(Cc2c[nH]c3c2cccc3)CC1

InChI

InChI=1S/C22H27N5O/c28-14-18-13-27(21-5-8-23-16-25-21)15-22(18)6-9-26(10-7-22)12-17-11-24-20-4-2-1-3-19(17)20/h1-5,8,11,16,18,24,28H,6-7,9-10,12-15H2/t18-/m1/s1

InChI Key

KNZDVGRWWNDHLR-GOSISDBHSA-N

MDL Number (MFCD)

MFCD29017057

KNZDVGRWWNDHLR-GOSISDBHSA-N in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Kinases
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with KNZDVGRWWNDHLR-GOSISDBHSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound KNZDVGRWWNDHLR-GOSISDBHSA-N?
Check Price and Availability of KNZDVGRWWNDHLR-GOSISDBHSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of KNZDVGRWWNDHLR-GOSISDBHSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for KNZDVGRWWNDHLR-GOSISDBHSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for KNZDVGRWWNDHLR-GOSISDBHSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of KNZDVGRWWNDHLR-GOSISDBHSA-N available by request